HER3 targeting with an antibody-drug conjugate bypasses resistance to anti-HER2 therapies

  1. Gandullo-Sánchez, L.
  2. Capone, E.
  3. Ocaña, A.
  4. Iacobelli, S.
  5. Sala, G.
  6. Pandiella, A.
Revue:
EMBO Molecular Medicine

ISSN: 1757-4684,  1757-4676

Année de publication: 2020

Volumen: 12

Número: 5

Type: Article

DOI: 10.15252/EMMM.201911498 GOOGLE SCHOLAR lock_openAccès ouvert editor